Cabozantinib and apixaban: an hitherto unreported interaction
Cabozantinib and apixaban: an hitherto unreported interaction
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
The use of direct oral anticoagulant in cancer patients is an emerging issue, which seems to be an alternative to low molecular weight heparin. Every year several new drugs are approved as anticancer treatment with possible drug-drug interaction with other drugs such as oral anticoagulant. We describe, for the first time, a case of neutropenia and...
Alternative Titles
Full title
Cabozantinib and apixaban: an hitherto unreported interaction
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_1b7232a7b34c45b4b14dc64c8cbaebe0
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1b7232a7b34c45b4b14dc64c8cbaebe0
Other Identifiers
ISSN
2162-3619
E-ISSN
2162-3619
DOI
10.1186/s40164-019-0146-9
